Inhibition of platelet activation, aggregation and/or adhesion by hypothermia
AssigneeZoll Circulation, Inc.
InventorsMichael W. Dae, Timothy R. Machold, Wade A. Keller
Life of this patent
Estimating the term…
Loading patent…
AssigneeZoll Circulation, Inc.
InventorsMichael W. Dae, Timothy R. Machold, Wade A. Keller
Estimating the term…
A method for treating acute coronary syndromes (i.e., unstable angina or non-Q-wave MI) or transient ischemic attacks in a human or animal patient by placing a heat exchange apparatus in the patient=s vasculature and using that heat exchange apparatus to cool the patient to a temperature (e.g. 30-36 degrees C.) at which platelet inhibition (i.e., inhibition of platelet activation and/or aggregation and/or adhesion) occurs. Anti-shivering drugs or anesthesia may be administered to patients whose body temperature is cooled below that patient=s shivering threshold (typically approximately 35.5 degrees C.). If it is determined that platelet inhibition is no longer desirable, such as when the patient is about to undergo a surgical or interventional procedure wherein bleeding could be problematic, the hypothermia-induced platelet inhibition may be rapidly reversed by using the intravascular heat exchange apparatus to re-warm the patient=s body to normothermia or near normothermia.
A method for causing platelet inhibition in a human or veterinary patient in whom an initial diagnosis or clinical impression has been reached indicating that the patient suffers from an acute coronary syndrome, transient ischemic attack or other disorder that may benefit from therapeutic platelet inhibition, said method comprising the steps of:
A method according to claim 14 wherein said fin comprises a bulge.
d according to claim 8 wherein the heat exchange apparatus is placed in the patient's vena cava.
A method according to claim 9 wherein the heat exchange apparatus is placed in the patient's inferior vena cava.
A method according to claim 9 wherein the e heat exchange apparatus is placed in the patient's superior vena cava.
according to claim 14 wherein said fin comprises a raised area on at least a blood-contacting surface of the heat exchanger.
according to claim 14 wherein said fin comprises a ridge.
21-43. (canceled)
Dependencies are inferred from the claim text.